Anti-PD1 antibodies in the adjuvant setting

被引:0
|
作者
Dreno, B. [1 ]
机构
[1] Nantes Univ, Dept Dermatol, Nantes, France
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
SY9.3
引用
收藏
页码:14 / 14
页数:1
相关论文
共 50 条
  • [1] How to build anti-PD1 agonist antibodies
    Alexandra Flemming
    Nature Reviews Immunology, 2023, 23 : 139 - 139
  • [2] How to build anti-PD1 agonist antibodies
    Flemming, Alexandra
    NATURE REVIEWS IMMUNOLOGY, 2023, 23 (03) : 139 - 139
  • [3] Biomarkers for Predicting Efficacies of Anti-PD1 Antibodies
    Kambayashi, Yumi
    Fujimura, Taku
    Hidaka, Takanori
    Aiba, Setsuya
    FRONTIERS IN MEDICINE, 2019, 6
  • [4] Management of melanoma recurrence following adjuvant anti-PD1 therapy
    Owen, C.
    Palmieri, D.
    Guminski, A.
    Carlino, M. S.
    Menzies, A. M.
    Long, G. V.
    ANNALS OF ONCOLOGY, 2018, 29
  • [5] Response to Anti-PD1/L1 Antibodies in Advanced Urothelial Cancer in the 'Real-Life' Setting
    Gadot, Moran
    Arad, Ido
    Atenafu, Eshetu G.
    Levartovsky, Meital
    Portnoy, Orith
    Davidson, Tima
    Schor-Bardach, Rachel
    Berger, Raanan
    Leibowitz, Raya
    PHARMACEUTICALS, 2022, 15 (09)
  • [6] Interchangeability of anti-PD1 antibodies in patients (pts) with metastatic NSCLC
    Kravchuk, Darya
    Fedyanin, Mikhail
    Ivan, Borovkov
    Moiseenko, Fedor Vladimirovich
    Zhukova, Lyudmila
    Pokataev, Ilya
    Rays, Anastasia
    Chubenko, Viacheslav
    Volkov, Nikita
    Ivanilov, Kirill
    Glazkova, Elena
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] Clinical Experiences With Anti-CD137 and Anti-PD1 Therapeutic Antibodies
    Ascierto, Paolo A.
    Simeone, Ester
    Sznol, Mario
    Fu, Yang-Xin
    Melero, Ignacio
    SEMINARS IN ONCOLOGY, 2010, 37 (05) : 508 - 516
  • [8] Metabolic factors affecting response to adjuvant anti-PD1 therapy for melanoma
    Bruno, Sabrina
    Knight, Andrew David
    Wang, Hong
    Sander, Cindy
    Karapetyan, Lilit
    Kirkwood, John M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] "Interchangeability" of anti-PD1 antibodies in patients (pts) with metastatic melanoma (mM)
    Kravchuk, Darya
    Fedyanin, Mikhail
    Rays, Anastasia
    Moiseenko, Fedor Vladimirovich
    Ivanilov, Kirill
    Popov, Vladimir
    Glazkova, Elena
    Chubenko, Viacheslav
    Levchenko, Evgeny
    Volkov, Nikita
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] A multicenter analysis of melanoma recurrence following adjuvant anti-PD1 therapy.
    Owen, Carina N.
    Larkin, James M. G.
    Shoushtari, Alexander Noor
    Carlino, Matteo S.
    Blank, Christian U.
    Lee, Belinda
    Mangana, Joanna
    Atkinson, Victoria
    Millward, Michael
    Zaman, Farzana
    Young, Arissa
    Khattak, Muhammad Adnan
    Patel, Sapna Pradyuman
    Hoeller, Christoph
    Hersey, Peter
    Chauhan, Dharmisha
    Palmieri, David James
    Lo, Serigne
    Menzies, Alexander M.
    Long, Georgina V.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)